We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$4.09B
AUM Growth
+$2.61B
Cap. Flow
+$2.46B
Cap. Flow %
60.1%
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$37.8M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$35.1M
3
TMUS icon
T-Mobile US
TMUS
+$30.4M
4
NU icon
Nu Holdings
NU
+$27.8M
5
ED icon
Consolidated Edison
ED
+$26.1M

Top Sells

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$17M
2
MRVL icon
Marvell Technology
MRVL
+$16.2M
3
NVO
Novo Nordisk
NVO
+$16.1M
4
NOW icon
ServiceNow
NOW
+$13.3M
5
WMT icon
Walmart Inc
WMT
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 15.87%
2 Industrials 14.69%
3 Financials 14.36%
4 Healthcare 12.68%
5 Consumer Discretionary 12.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AES icon
1601
AES
AES
$10.6B
-101,596
Closed -$1.26M
AGL icon
1602
Agilon Health
AGL
$1.55B
-1,785
Closed -$193K
AGNC icon
1603
AGNC Investment
AGNC
$12.7B
-27,766
Closed -$266K
AHCO icon
1604
AdaptHealth
AHCO
$1.47B
-10,495
Closed -$114K
AHRT
1605
AH Realty Trust
AHRT
$536M
-80,660
Closed -$606K
AIP icon
1606
Arteris
AIP
$1.24B
-47,491
Closed -$328K
AIQ icon
1607
Global X Artificial Intelligence & Technology ETF
AIQ
$8.89B
-5,696
Closed -$207K
ALHC icon
1608
Alignment Healthcare
ALHC
$3.78B
-61,154
Closed -$1.14M
ALLO icon
1609
Allogene Therapeutics
ALLO
$625M
-43,940
Closed -$64.2K
ALNY icon
1610
Alnylam Pharmaceuticals
ALNY
$38.3B
-3,720
Closed -$1M
AMAL icon
1611
Amalgamated Financial
AMAL
$1.47B
-16,126
Closed -$464K
AMCX icon
1612
AMC Global Media
AMCX
$450M
-90,911
Closed -$625K
AMD icon
1613
Advanced Micro Devices
AMD
$700B
-4,841
Closed -$497K
AMP icon
1614
Ameriprise Financial
AMP
$47.8B
-1,245
Closed -$603K
AMZN icon
1615
Amazon
AMZN
$2.44T
-6,224
Closed -$1.18M
ANET icon
1616
Arista Networks
ANET
$199B
-218,796
Closed -$17M
ANNX icon
1617
Annexon
ANNX
$796M
-65,918
Closed -$127K
APD icon
1618
Air Products & Chemicals
APD
$65.5B
-8,684
Closed -$2.56M
ARES icon
1619
Ares Management
ARES
$28.1B
-19,547
Closed -$2.87M
ASB icon
1620
Associated Banc-Corp
ASB
$5.8B
-40,522
Closed -$913K
EFOR
1621
Everforth Inc
EFOR
$960M
-11,304
Closed -$712K
ASML icon
1622
ASML
ASML
$596B
-316
Closed -$209K
ATI icon
1623
ATI
ATI
$24.3B
-64,556
Closed -$3.36M
AUPH icon
1624
Aurinia Pharmaceuticals
AUPH
$1.95B
-17,410
Closed -$140K
AVAV icon
1625
AeroVironment
AVAV
$7.19B
-3,677
Closed -$438K

Similar funds

Y-Intercept (HK)'s Q2 2025 Portfolio in Review

As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.

  • Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
  • Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
  • Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
  • Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
  • Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
  • Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
  • Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.

Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.